US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SKHY $195.02 ▲+0.00% SNDK $1,704.16 ▲+0.00% SDEV $3.94 ▲+0.00% TSLA $378.73 ▲+0.00% INTC $116.19 ▲+0.00%
FinancialContent

Articles published by Teva Pharmaceutical Industries Ltd; Alvotech

News headline image
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
From Teva Pharmaceutical Industries Ltd; Alvotech
Via GlobeNewswire
Tickers ALVO TEVA